Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prolactin as a modulator of B cell function: implications for SLE.

Elena Peeva1, Jeganathan Venkatesh, Daniel Michael

  • 1Department of Microbiology and Immunology, Albert Einstein College of Medicine, Rm. 405, Forch Building, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|June 15, 2004
PubMed
Summary

Prolactin, a hormone involved in immunity, may play a key role in Systemic Lupus Erythematosus (SLE). Lowering prolactin levels shows promise for treating this autoimmune disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid Onset of Response in Adults with Dermatomyositis Receiving Dazukibart: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study.

Clinical, cosmetic and investigational dermatology·2026
Same author

A phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of PF-07261271 in healthy participants.

British journal of clinical pharmacology·2026
Same author

Serum proteomic atlas reveals distinct molecular signatures of lupus nephritis activity, chronicity, and treatment response.

bioRxiv : the preprint server for biology·2026
Same author

An efficient approach to study ANA⁺ B cells in autoimmune diseases integrating flow cytometry with single-cell analysis.

Molecular medicine (Cambridge, Mass.)·2026
Same author

Six-Month Outcomes in Children With COVID-19 or Multisystem Inflammatory Syndrome in Children.

Hospital pediatrics·2026
Same author

Spatially Distinct Macrophage Subsets Drive Myofibroblast Heterogeneity and Maladaptive Fibrosis in Lupus Nephritis.

bioRxiv : the preprint server for biology·2026

Area of Science:

  • Immunology
  • Endocrinology
  • Autoimmunity

Background:

  • Prolactin is an immunomodulator affecting lymphocyte function.
  • Elevated prolactin levels are observed in Systemic Lupus Erythematosus (SLE) patients.
  • Prolactin is implicated in the development and progression of autoimmune diseases like SLE.

Purpose of the Study:

  • To investigate the role of prolactin in SLE pathogenesis.
  • To explore prolactin's impact on B cell tolerance and maturation.
  • To assess the therapeutic potential of manipulating prolactin levels in SLE.

Main Methods:

  • Analysis of serum prolactin levels in lupus patients and lupus-prone mice.
  • Administration of prolactin to induce lupus-like illness in susceptible mice.

Related Experiment Videos

  • Investigation of prolactin's effects on B cell subsets and tolerance mechanisms.
  • Evaluation of bromocriptine's efficacy in murine lupus models.

    • Main Results:

    • Increased prolactin levels correlate with disease severity and mortality in murine lupus.
    • Prolactin administration breaks tolerance and induces lupus-like disease in genetically susceptible mice.
    • Prolactin promotes the maturation of autoreactive B cells into follicular B cells.
    • CD4+ T cells are essential for prolactin-mediated B cell tolerance breakdown.
    • Bromocriptine treatment shows beneficial effects in murine lupus.

    Conclusions:

    • Prolactin is a significant factor in SLE pathogenesis, particularly in genetically susceptible individuals.
    • Prolactin's effects on B cell maturation and tolerance contribute to autoimmunity.
    • Targeting prolactin or susceptible follicular B cells may offer novel therapeutic strategies for a subset of SLE patients.